Effect of carvedilol on venous return: A mechanism of reduction in blood pressure.

Ishibashi, Takaharu; Okuhira, Masayasu; Hamaguchi, Masami; Katsumata, Naoki; Nakazawa, Makoto; Imai, Shoichi

doi:10.1254/jjp.55.186

Cited by 3 publications

(1 citation statement)

References 7 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…symptoms, [48][49][50] right ventricular remodeling, and improved exercise duration [51]. Combined angiotensin-receptor and neprilysin inhibitors (ARNIs), which have been extensively studied in acquired HF [52] Currently, OHT wait-list mortality or delisting due to worsening clinical status is disproportionately common for ACHD patients listed as status 1A in the United States [61].…”

Section: Accepted Manuscriptmentioning

confidence: 99%

Long Term Consequences of the Fontan Procedure and How to Manage Them

Kay

Moe

Suter

et al. 2018

Progress in Cardiovascular Diseases

View full text Add to dashboard Cite

In 1971, Fontan and Baudet described a surgical technique for successful palliation of patients with tricuspid atresia. Subsequently, this technique has been applied to treat most forms of functional single ventricles and has become the current standard of care for long-term palliation of all patients with single ventricle congenital heart disease. Since 1971, the Fontan procedure has undergone several variations. These patients require lifelong management including a thorough knowledge of their anatomic substrate, hemodynamic status, management of rhythm and ventricular function along with multi organ evaluation. As these patients enter middle age, there is increasing awareness regarding the long-term complications and mortality. This review highlights the long-term outcomes of the Fontan procedure and management of late sequelae.

show abstract